Zhiguang Zhou Selected Research

Fibroblast Growth Factors (Fibroblast Growth Factor)

3/2021	Decreased serum fibroblast growth factor 19 level is a risk factor for type 1 diabetes.
1/2020	Fibroblast Growth Factor 19 Levels Predict Subclinical Atherosclerosis in Men With Type 2 Diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhiguang Zhou Research Topics

Disease

110	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2024 - 03/2005
80	Type 2 Diabetes Mellitus (MODY) 03/2024 - 11/2003
39	Latent Autoimmune Diabetes in Adults 12/2023 - 11/2003
25	Insulin Resistance 02/2024 - 01/2005
24	Obesity 05/2024 - 01/2013
21	Inflammation (Inflammations) 09/2023 - 03/2005
17	Autoimmune Diseases (Autoimmune Disease) 10/2023 - 08/2014
15	Hyperglycemia 02/2024 - 06/2011
12	Body Weight (Weight, Body) 12/2021 - 06/2011
11	Diabetes Mellitus 12/2023 - 04/2002
11	Hypoglycemia (Reactive Hypoglycemia) 01/2023 - 01/2013
10	Diabetes Complications 02/2024 - 11/2003
10	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023 - 03/2010
8	Neoplasms (Cancer) 01/2023 - 01/2013
8	Atherosclerosis 01/2020 - 04/2010
7	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 04/2015
6	Infections 12/2023 - 04/2013
6	Ketosis 01/2023 - 03/2010
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 06/2015
6	Prediabetic State (Prediabetes) 01/2023 - 03/2010
6	Insulinoma 01/2023 - 10/2012
6	Dyslipidemias (Dyslipidemia) 01/2023 - 11/2003
5	Weight Gain 11/2023 - 01/2017
5	Hypertension (High Blood Pressure) 01/2023 - 11/2003
5	COVID-19 01/2023 - 01/2020
4	Weight Loss (Weight Reduction) 09/2023 - 11/2014
4	Disease Progression 01/2022 - 01/2015
4	Glucose Intolerance 08/2014 - 03/2010
3	Hypersensitivity (Allergy) 10/2023 - 01/2011
3	Virus Diseases (Viral Diseases) 10/2023 - 01/2019
3	Pathologic Processes 01/2022 - 01/2020
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 08/2010
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 03/2015
3	Coronary Artery Disease (Coronary Atherosclerosis) 12/2014 - 05/2013
2	Muscle Cramp (Cramp) 04/2023 - 01/2020
2	Bone Resorption 01/2023 - 01/2021
2	Overweight 01/2023 - 01/2023

Drug/Important Bio-Agent (IBA)

64	Insulin (Novolin)FDA Link 05/2024 - 11/2003
38	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 03/2010
34	AutoantibodiesIBA 01/2023 - 11/2003
22	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 12/2023 - 11/2003
16	C-PeptideIBA 12/2023 - 11/2003
12	Blood Glucose (Blood Sugar)IBA 11/2023 - 07/2010
12	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2010
11	LipidsIBA 01/2023 - 01/2013
10	Metformin (Glucophage)FDA LinkGeneric 01/2023 - 01/2013
9	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2024 - 07/2010
8	MicroRNAs (MicroRNA)IBA 02/2024 - 10/2014
8	AntigensIBA 10/2023 - 01/2012
7	Biomarkers (Surrogate Marker)IBA 12/2023 - 12/2015
7	Hypoglycemic Agents (Hypoglycemics)IBA 09/2020 - 03/2005
6	Circular RNAIBA 12/2023 - 01/2021
6	Zinc Transporter 8IBA 01/2023 - 10/2010
6	EnzymesIBA 01/2023 - 06/2015
6	Insulin Glargine (Lantus)FDA Link 06/2022 - 11/2016
6	CytokinesIBA 01/2021 - 01/2015
6	AntibodiesIBA 10/2020 - 06/2011
6	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2020 - 01/2014
5	HLA Antigens (Human Leukocyte Antigens)IBA 12/2023 - 10/2014
5	CreatinineIBA 10/2020 - 11/2016
5	Transcription Factors (Transcription Factor)IBA 06/2019 - 12/2013
4	oxidized low density lipoproteinIBA 05/2024 - 10/2017
4	Therapeutic UsesIBA 03/2024 - 09/2012
4	CholesterolIBA 01/2023 - 04/2010
4	Vitamin D FDA LinkGeneric 01/2023 - 07/2009
4	ZincIBA 01/2022 - 10/2010
4	ProinsulinIBA 01/2022 - 01/2016
4	C-Reactive ProteinIBA 01/2021 - 01/2005
4	Fatty Acid-Binding ProteinsIBA 01/2021 - 04/2010
4	Sitagliptin Phosphate (Januvia)FDA Link 01/2021 - 05/2014
3	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2015
3	VaccinesIBA 10/2023 - 01/2011
3	Monoclonal AntibodiesIBA 01/2023 - 01/2015
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2023 - 01/2018
3	LY2963016 insulin glargineIBA 06/2022 - 10/2021
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2015
3	Triglycerides (Triacylglycerol)IBA 01/2021 - 03/2010
3	AdiponectinIBA 01/2021 - 03/2010
3	Interleukin-10 (Interleukin 10)IBA 01/2021 - 01/2016
3	Indicators and Reagents (Reagents)IBA 01/2021 - 09/2012
3	Immunoglobulin A (IgA)IBA 12/2020 - 01/2019
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2020 - 03/2019
3	Immunoglobulin M (IgM)IBA 01/2019 - 01/2011
3	Histones (Histone)IBA 01/2019 - 10/2014
3	ThiazolidinedionesIBA 04/2013 - 03/2005
2	Hemoglobins (Hemoglobin)IBA 03/2024 - 01/2023
2	Insulin Lispro (Humalog)FDA Link 01/2024 - 04/2017
2	CathelicidinsIBA 04/2023 - 01/2020
2	UbiquitinIBA 01/2023 - 01/2017
2	OsteocalcinIBA 01/2023 - 01/2021
2	CarbohydratesIBA 01/2023 - 11/2021
2	Antiviral Agents (Antivirals)IBA 01/2023 - 10/2020
2	Glucagon (Glukagon)FDA Link 01/2023 - 01/2021

Therapy/Procedure

45	Therapeutics 10/2023 - 05/2008
21	Glycemic Control 01/2023 - 01/2013
9	Bariatric Surgery 09/2023 - 11/2018
6	Gastrectomy 09/2023 - 01/2019
3	Immunotherapy 01/2023 - 01/2015
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 01/2013
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 09/2023 - 05/2022